Immunome (IMNM) News Today $10.58 +0.13 (+1.24%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$10.83 +0.25 (+2.40%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMNM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Immunome, Inc. (NASDAQ:IMNM) Receives $23.33 Average PT from BrokeragesJuly 17 at 2:03 AM | americanbankingnews.comImmunome (NASDAQ:IMNM) Shares Up 8.6% - What's Next?July 16, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Stock Price Down 5.5% - Here's WhyJuly 15, 2025 | marketbeat.com38,501 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by Private Capital Advisors Inc.July 14, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Receives Consensus Recommendation of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | businesswire.comImmunome (NASDAQ:IMNM) Shares Down 7.8% - Here's WhyJuly 1, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 4% - Should You Sell?June 25, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Receives Average Rating of "Buy" from AnalystsJune 19, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 6.7% - Should You Sell?June 13, 2025 | marketbeat.comBank of America Corp DE Sells 44,020 Shares of Immunome, Inc. (NASDAQ:IMNM)June 12, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Shares Sold by Jane Street Group LLCJune 7, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 5, 2025 | businesswire.comLifesci Capital Has Positive Outlook of Immunome Q2 EarningsJune 5, 2025 | marketbeat.comTwo Sigma Advisers LP Makes New $512,000 Investment in Immunome, Inc. (NASDAQ:IMNM)June 5, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Director Buys $46,900.00 in StockJune 4, 2025 | marketbeat.comInsider Buying: Immunome, Inc. (NASDAQ:IMNM) Director Buys 5,000 Shares of StockJune 4, 2025 | insidertrades.comTwo Sigma Investments LP Purchases Shares of 154,467 Immunome, Inc. (NASDAQ:IMNM)June 3, 2025 | marketbeat.comMillennium Management LLC Buys New Position in Immunome, Inc. (NASDAQ:IMNM)June 3, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Up 4.5% - Here's WhyMay 30, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Buy" by BrokeragesMay 26, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Shares Bought by Woodline Partners LPMay 25, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Shares Acquired by Northern Trust CorpMay 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Raises Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)May 22, 2025 | marketbeat.comImmunome, Inc. Reports Q1 2025 Financial ResultsMay 20, 2025 | tipranks.comJanus Henderson Group PLC Has $36.73 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)May 17, 2025 | marketbeat.comCubist Systematic Strategies LLC Invests $902,000 in Immunome, Inc. (NASDAQ:IMNM)May 17, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Gap Up on Better-Than-Expected EarningsMay 15, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPSMay 14, 2025 | marketbeat.comGranahan Investment Management LLC Takes $3.34 Million Position in Immunome, Inc. (NASDAQ:IMNM)May 13, 2025 | marketbeat.comImmunome Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 12, 2025 | finance.yahoo.comEnavate Sciences GP LLC Acquires New Holdings in Immunome, Inc. (NASDAQ:IMNM)May 11, 2025 | marketbeat.comImmunome (IMNM) to Release Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comInvesco Ltd. Cuts Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)May 6, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Has $24.24 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)May 4, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of "Buy" from BrokeragesMay 2, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Stock Holdings Raised by Adage Capital Partners GP L.L.C.May 1, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Sells 262,059 Shares of Immunome, Inc. (NASDAQ:IMNM)April 28, 2025 | marketbeat.comRenaissance Technologies LLC Purchases 304,700 Shares of Immunome, Inc. (NASDAQ:IMNM)April 26, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Stake Cut by Marshall Wace LLPApril 23, 2025 | marketbeat.comJPMorgan Chase & Co. Acquires 624,045 Shares of Immunome, Inc. (NASDAQ:IMNM)April 19, 2025 | marketbeat.comImmunome: Transformed Pipeline Offers Multiple CatalystsApril 17, 2025 | seekingalpha.comVanguard Group Inc. Sells 128,130 Shares of Immunome, Inc. (NASDAQ:IMNM)April 15, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Reaches New 1-Year Low - Time to Sell?April 9, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Buy" by BrokeragesApril 7, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Stock Price Up 4.4% - Time to Buy?April 4, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Coverage Initiated by Analysts at Lake Street CapitalApril 4, 2025 | marketbeat.comImmunome initiated with a Buy at Lake StreetApril 3, 2025 | markets.businessinsider.comImmunome (NASDAQ:IMNM) Stock Price Down 6.7% - What's Next?April 3, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 3, 2025 | businesswire.com Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address IMNM Media Mentions By Week IMNM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼0.900.59▲Average Medical News Sentiment IMNM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼54▲IMNM Articles Average Week Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KYMR News Today MOR News Today HCM News Today RARE News Today ALVO News Today AMRX News Today MIRM News Today CPRX News Today ARWR News Today IBRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
